We could not find any results for:
Make sure your spelling is correct or try broadening your search.
CHICAGO, June 05, 2023 (GLOBE NEWSWIRE) -- Shanghai Escugen Biotechnology Co., Ltd. (“Escugen”), a partner of Levena (Suzhou) Biopharma Co., Ltd. (“Levena”), a wholly owned subsidiary of...
A California-based biotech company is turning heads Wednesday morning after it was announced that the U.S. Bankruptcy Court granted an interim approval of the company’s $75 To read the full...
Sorrento Therapeutics, Inc. Receives Court Approval for $75 Million Financing in Chapter 11 Case PR Newswire SAN DIEGO, Feb. 21, 2023 SAN DIEGO, Feb. 21, 2023 /PRNewswire/ -- Sorrento...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | -7.7927 | -96.2061728395 | 8.1 | 8.275 | 0.161 | 12490108 | 1.76242239 | CS |
260 | -2.1127 | -87.3016528926 | 2.42 | 21.26 | 0.161 | 14577604 | 6.00231043 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions